Get the weekly note
ETFIQetfiq.com · independent ETF data

Data as of .

LENS vs LFSC: which is really different?

LENS and LFSC hold 0% of their weight in the same names, and LFSC returned more over the year.

Sarmaya Thematic ETF and F/m Emerald Life Sciences Innovation ETF.

21.7%LENS in the S&P 500
0.0%LFSC in the S&P 500
+46.4%LENS total return, 1 year
+53.0%LFSC total return, 1 year

ETFIQ Off-Index Score: LFSC scores higher

How much of it is not the index it is sold as an alternative to?

LENS 48LFSC 91.80.1, the lowest in this set91.8, the highest

A percentile among the 379 thematic ETFs with a holdings filing. It is a position in a set, not a rating, and neither end of it is a recommendation. All thematic ETFs ranked by it · How it is computed

LENS78% of its weight is outside the S&P 500 · 1 year to Sep 18, 2026
22%78%in the S&P 500of its weight outside the S&P 500active share 98% · top ten 42% of the fund · 43 holdings filed May 29, 2026 · Nasdaq-100: 2% in22%78%inoutside the S&P 500active share 98% · top ten 42% of the fund
LFSC100% of its weight is outside the S&P 500 · 1 year to Sep 18, 2026
0%100%0% of its weight in S&P 500 companiesof its weight outside the S&P 500active share 100% · top ten 55% of the fund · 39 holdings filed May 31, 2026 · Nasdaq-100: 1% in0%100%0% of its weight in S&P 500 companiesof its weight outside the S&P 500active share 100% · top ten 55% of the fund

0% of the two portfolios are the same securities at the same weight.

What they hold in common

By the books each fund has filed, LENS and LFSC hold 0% of their money in the same securities at the same weight.

Only in each
Only in LENSOnly in LFSC
SPDR Gold MiniShares Trust 9.04%Travere Therapeutics Inc 7.66%
iShares Gold Trust Micro 5.81%Cogent Biosciences Inc 7.52%
Chevron Corp 4.22%LivaNova PLC 7.11%
Exxon Mobil Corp 4.22%Spyre Therapeutics Inc 6.41%
iShares Silver Trust 4.22%Guardant Health Inc 5.51%
Kinross Gold Corp 3.96%Mirum Pharmaceuticals Inc 4.92%
Agnico Eagle Mines Ltd 3.03%Corcept Therapeutics Inc 4.79%
Gold Fields Ltd 2.85%United Therapeutics Corp 4.15%

Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated May 29, 2026 and May 31, 2026.

Performance, window by window

LENS and LFSC over each window. Every figure is an ETFIQ calculation with distributions reinvested. Source: ETFIQ.
WindowTotal returnvs the S&P 500vs the Nasdaq-100
LENSLFSCLENSLFSCLENSLFSC
3 months+12.1%+8.7%+9.9 pts+6.5 pts+14.6 pts+11.2 pts
6 months+6.7%+36.0%−11.3 pts+17.9 pts−17.5 pts+11.7 pts
1 year+46.4%+53.0%+29.8 pts+36.5 pts+24.6 pts+31.3 pts
Since launch+84.9%+81.3%+55.8 pts+44.3 pts+45.4 pts+30.9 pts
Open the live comparison on ETFIQ
LENS and LFSC on the same fields, as of Sep 18, 2026. Source: ETFIQ.
LENS
Sarmaya Thematic ETF
Holds 43 stocks in broad innovation and megatrends, 22% of its weight in S&P 500 companies
LFSC
F/m Emerald Life Sciences Innovation ETF
Holds 39 stocks in broad innovation and megatrends, 0% of its weight in S&P 500 companies
IssuerSarmayaF/m
ThemeBroad innovation and megatrendsBroad innovation and megatrends
In the S&P 50021.7%0.0%
Active share vs the S&P 50097.9%100.0%
In the Nasdaq-1001.7%0.6%
Holdings4339
Top ten, share of the fund42.3%54.7%
Expense ratio0.79%0.54%
Fee for the differing part0.81%0.54%
Total return, 1 year+46.4%+53.0%
vs the S&P 500+29.8 pts+36.5 pts
vs the Nasdaq-100+24.6 pts+31.3 pts
Below its high−9.8%−6.8%
Net assets$53m$105m

LENS in plain words

By weight, 22% of LENS's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 42% of the fund across 43 positions, as filed for May 29, 2026. Over the year to Sep 18, 2026 the fund returned +46.4% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 29.8 pts. It sits 9.8% below its all-time high of Feb 27, 2026.

LFSC in plain words

By weight, 0% of LFSC's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 100%. The top ten holdings are 55% of the fund across 39 positions, as filed for May 31, 2026. Over the year to Sep 18, 2026 the fund returned +53.0% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 36.5 pts. It sits 6.8% below its all-time high of Aug 19, 2026.

Questions people ask

Do LENS and LFSC hold the same stocks?
By their latest filings, 0% of their books are the same securities at the same weight, which is mostly different names. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, LENS or LFSC?
LENS has 22% of its weight in S&P 500 names and LFSC has 0%, so LFSC differs more from the index.
Which is cheaper, LENS or LFSC?
LENS charges 0.79% a year and LFSC charges 0.54%, so LFSC is cheaper. Fees come from each fund's prospectus.

Other comparisons

Where these figures came from

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

LENS against LFSC, ETFIQ, data as of Sep 18, 2026. Every figure is calculated from a named public source; the method is at etfiq.com/methodology. A comparison is not a recommendation.

Cite this page. ETFIQ, LENS against LFSC, data as of Sep 18, 2026. https://etfiq.com/compare/themes/lens-vs-lfsc Free to use with attribution; the underlying files are at Open data.

How every figure is computed · Standards and sources